HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chini, C. C.S. Articles by Dousa, T. P. Search for Related Content PubMed PubMed Citation Articles by Chini, C. C.S. Articles by Dousa, T. P. Social Bookmarking                      What's this?

Volume 272, Number 15, Issue of April 11, 1997 pp. 9854-9859
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Compartmentalization of cAMP Signaling in Mesangial Cells by Phosphodiesterase Isozymes PDE3 and PDE4
REGULATION OF SUPEROXIDATION AND MITOGENESIS

(Received for publication, July 2, 1996, and in revised form, February 7, 1997)

Claudia C. S. Chini , Joseph P. Grande , Eduardo N. Chini and Thomas P. Dousa

From the Renal Pathophysiology Laboratory, Department of Physiology and Biophysics, and the  Department of Laboratory Medicine, Mayo Clinic and Foundation, Mayo Medical School, Rochester, Minnesota 55905

Some major pathobiologic processes in renal mesangial cells, elicited in response to immunoinflammatory stimuli, are modulated via cAMP-protein kinase A (PKA) signaling pathways; namely, generation of reactive oxygen metabolites (ROM) and accelerated proliferation of mesangial cells. We investigated the role of cAMP phosphodiesterase (PDE) isozymes in these regulatory mechanisms. Generation of ROM in cultured rat mesangial cells was inhibited by selective inhibitors of PDE4, rolipram and denbufylline, whereas PDE3 inhibitors, cilostamide and lixazinone, had no effect. Conversely, cilostamide or lixazinone suppressed mitogenic synthesis of DNA in mesangial cells, but 1 µM rolipram or 1 µM denbufylline showed no inhibitory effect. The efficacy of PDE isozyme inhibitors (IC₅₀) to suppress [³H]thymidine incorporation or ROM generation paralleled IC₅₀ values for inhibition of cAMP PDE. Incubation of mesangial cells with either rolipram alone or with cilostamide alone increased significantly in situ activity of PKA in mesangial cells, assessed by (cAMP/+cAMP) PKA activity ratio, and the stimulatory effects were additive. Results indicate that in mesangial cells a cAMP pool that is metabolized by PDE4 activates PKA and thereby inhibits ROM generation; another cAMP pool that is metabolized by PDE3 activates another PKA (isozyme or pool) which suppresses proliferation of mesangial cells. We propose that in mesangial cells, a cAMP-PKA pathway that regulates mitogenesis is determined by activity of PDE3, whereas another cAMP-PKA pathway is directed by activity of PDE4 and controls ROM generation. Therefore, two PDE isozymes within one cell type compartmentalize distinct cAMP signaling pathways.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				W. J. Perkins, M. Taniguchi, D. O. Warner, E. N. Chini, and K. A. Jones Reduction in soluble guanylyl cyclase-specific activity following prolonged treatment of porcine pulmonary artery with nitric oxide Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L84 - L95. [Abstract] [Full Text] [PDF]

				J. Cheng and J. P. Grande Cyclic Nucleotide Phosphodiesterase (PDE) Inhibitors: Novel Therapeutic Agents for Progressive Renal Disease Experimental Biology and Medicine, January 1, 2007; 232(1): 38 - 51. [Abstract] [Full Text] [PDF]

				J. Cheng, M. A. Thompson, H. J. Walker, C. E. Gray, G. M. Warner, W. Zhou, and J. P. Grande Lixazinone stimulates mitogenesis of madin-darby canine kidney cells. Experimental Biology and Medicine, March 1, 2006; 231(3): 288 - 295. [Abstract] [Full Text] [PDF]

				Z. Yang, L. D. Asico, P. Yu, Z. Wang, J. E. Jones, C. S. Escano, X. Wang, M. T. Quinn, D. R. Sibley, G. G. Romero, et al. D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R96 - R104. [Abstract] [Full Text] [PDF]

				J. Cheng, M. M. D. Encarnacion, G. M. Warner, C. E. Gray, K. A. Nath, and J. P. Grande TGF-{beta}1 stimulates monocyte chemoattractant protein-1 expression in mesangial cells through a phosphodiesterase isoenzyme 4-dependent process Am J Physiol Cell Physiol, October 1, 2005; 289(4): C959 - C970. [Abstract] [Full Text] [PDF]

				J. Cheng, M. A. Thompson, H. J. Walker, C. E. Gray, M. M. Diaz Encarnacion, G. M. Warner, and J. P. Grande Differential regulation of mesangial cell mitogenesis by cAMP phosphodiesterase isozymes 3 and 4 Am J Physiol Renal Physiol, November 1, 2004; 287(5): F940 - F953. [Abstract] [Full Text] [PDF]

				K. E. Broderick, M. R. MacPherson, M. Regulski, T. Tully, J. A. T. Dow, and S. A. Davies Interactions between epithelial nitric oxide signaling and phosphodiesterase activity in Drosophila Am J Physiol Cell Physiol, November 1, 2003; 285(5): C1207 - C1218. [Abstract] [Full Text] [PDF]

				D. H. Maurice, D. Palmer, D. G. Tilley, H. A. Dunkerley, S. J. Netherton, D. R. Raymond, H. S. Elbatarny, and S. L. Jimmo Cyclic Nucleotide Phosphodiesterase Activity, Expression, and Targeting in Cells of the Cardiovascular System Mol. Pharmacol., September 1, 2003; 64(3): 533 - 546. [Abstract] [Full Text] [PDF]

				H. A. Dunkerley, D. G. Tilley, D. Palmer, H. Liu, S. L. Jimmo, and D. H. Maurice Reduced Phosphodiesterase 3 Activity and Phosphodiesterase 3A Level in Synthetic Vascular Smooth Muscle Cells: Implications for Use of Phosphodiesterase 3 Inhibitors in Cardiovascular Tissues Mol. Pharmacol., May 1, 2002; 61(5): 1033 - 1040. [Abstract] [Full Text] [PDF]

				S. J. Netherton, S. L. Jimmo, D. Palmer, D. G. Tilley, H. A. Dunkerley, D. R. Raymond, J. C. Russell, P. M. Absher, E. H. Sage, R. B. Vernon, et al. Altered Phosphodiesterase 3-Mediated cAMP Hydrolysis Contributes to a Hypermotile Phenotype in Obese JCR:LA-cp Rat Aortic Vascular Smooth Muscle Cells: Implications for Diabetes-Associated Cardiovascular Disease Diabetes, April 1, 2002; 51(4): 1194 - 1200. [Abstract] [Full Text] [PDF]

				E. Moon, R. Lee, R. Near, L. Weintraub, S. Wolda, and A. Lerner Inhibition of PDE3B Augments PDE4 Inhibitor-induced Apoptosis in a Subset of Patients with Chronic Lymphocytic Leukemia Clin. Cancer Res., February 1, 2002; 8(2): 589 - 595. [Abstract] [Full Text] [PDF]

				J. H. Schwartz The many dimensions of cAMP signaling PNAS, November 20, 2001; 98(24): 13482 - 13484. [Full Text] [PDF]

				M. T. Osinski, B. H. Rauch, and K. Schrör Antimitogenic Actions of Organic Nitrates Are Potentiated by Sildenafil and Mediated Via Activation of Protein Kinase A Mol. Pharmacol., April 16, 2001; 59(5): 1044 - 1050. [Abstract] [Full Text]

				E. Feraille and A. Doucet Sodium-Potassium-Adenosinetriphosphatase-Dependent Sodium Transport in the Kidney: Hormonal Control Physiol Rev, January 1, 2001; 81(1): 345 - 418. [Abstract] [Full Text] [PDF]

				F. G. S. de Toledo, J. Cheng, M. Liang, E. N. Chini, and T. P. Dousa ADP-Ribosyl Cyclase in Rat Vascular Smooth Muscle Cells : Properties and Regulation Circ. Res., June 9, 2000; 86(11): 1153 - 1159. [Abstract] [Full Text] [PDF]

				V. Scivittaro, M. B. Ganz, and M. F. Weiss AGEs induce oxidative stress and activate protein kinase C-beta II in neonatal mesangial cells Am J Physiol Renal Physiol, April 1, 2000; 278(4): F676 - F683. [Abstract] [Full Text] [PDF]

				B. Bielekova, A. Lincoln, H. McFarland, and R. Martin Therapeutic Potential of Phosphodiesterase-4 and -3 Inhibitors in Th1-Mediated Autoimmune Diseases J. Immunol., January 15, 2000; 164(2): 1117 - 1124. [Abstract] [Full Text] [PDF]

				J. A. Melendez, R. P. Melathe, A. M. Rodriguez, J. E. Mazurkiewicz, and K. J. A. Davies Nitric Oxide Enhances the Manganese Superoxide Dismutase-dependent Suppression of Proliferation in HT-1080 Fibrosarcoma Cells Cell Growth Differ., September 1, 1999; 10(9): 655 - 664. [Abstract] [Full Text]

				T. P. Dousa Cyclic Nucleotide Phosphodiesterases: New Role in the Pathogenesis of Glomerulonephritis? Physiology, February 1, 1998; 13(1): 51 - 52. [Full Text] [PDF]

				Y. Shakur, K. Takeda, Y. Kenan, Z.-X. Yu, G. Rena, D. Brandt, M. D. Houslay, E. Degerman, V. J. Ferrans, and V. C. Manganiello Membrane Localization of Cyclic Nucleotide Phosphodiesterase 3 (PDE3). TWO N-TERMINAL DOMAINS ARE REQUIRED FOR THE EFFICIENT TARGETING TO, AND ASSOCIATION OF, PDE3 WITH ENDOPLASMIC RETICULUM J. Biol. Chem., December 1, 2000; 275(49): 38749 - 38761. [Abstract] [Full Text] [PDF]

				C. Marfella-Scivittaro, A. Quinones, and S. A. Orellana cAMP-dependent protein kinase and proliferation differ in normal and polycystic kidney epithelia Am J Physiol Cell Physiol, April 1, 2002; 282(4): C693 - C707. [Abstract] [Full Text] [PDF]